Latest News｜Institute for Biotechnology and Medicine Industry│IBMI

Industry News

IBMI

Subject
Taiwan's health ministry upgrades 3 hospitals to 'medical centers'
Taiwan biomanufacturer aims to be ‘biotech TSMC’
Chang Gung Medical Foundation and Boehringer Ingelheim Taiwan forge strategic partnership for clinical trials
Chang Gung Memorial Hospital to build smart ward in Malaysia
Inventec to boost biomedical startup incubation
Taiwan has successfully been included in the list of third countries for APIs, indicative of the regulatory system recognized by the European Union
Taiwan Bio signs pact with US-based TRACT Therapeutics
HIMSS and Taiwan’s National Health Insurance Administration Form Agreement to Drive Digital Transformation Through International Collaboration
China Medical University Hospital achieves triple HIMSS validations
ITRI Excels with Eight 2023 R&D 100 Awards, Showcasing Biotechnological Triumph
Taiwanese firm TaiGen Biopharma to develop and commercialise new drug in Malaysia and Singapore
Taiwan's medtech startup Flat Medical secures funding for global market expansion
TFBS Bioscience opens a branch office in Japan to boost viral vector production business
Drugs made in Taiwan snag and expect more market approvals
EirGenix wins a long-term contract for Japanese market
Taiwan researchers make breakthrough in treating brain trauma in mice
Novel therapeutics, medical devices do not necessarily tie with NHI coverage: Pan-Chyr Yang, VP of IBMI
DSFederal and Taipei Medical University Forge Partnership to Promote Innovation in Data Science Tech
Digital health faces regulatory challenges: Pan-Chyr Yang, VP of IBMI
Chung-Ho Memorial Hospital in Taiwan achieves Stage 6 EMRAM
Taiwan-based Formosa Pharma inks $86 M worth ophthalmology deal with American firm Eyenovia
Bora acquires six US brand product licenses, rights
Qisda ‘confident’ on Q3 sales
AI has prospects in smart healthcare: Barry Lam
Biomedical investor summit to be held in spring 2024 in Taiwan
Taiwan tops ranking in Numbeo’s 'Global Health Care Index by Country'
DKSH unveils largest automated healthcare distribution centre in Taiwan
Taiwan attracts foreigners to come for reproductive medicine and cancer treatment
Acepodia Presents Data on its Allogeneic Natural Killer-Like Gamma-Delta T Cell Therapy, ACE1831, in Development for Hematological Cancers
Taiwan has the most particle therapy facilities in terms of population density
Newsweek lists National Taiwan University Hospital as one of world’s best
Medical device developer MiiS’ AI-DR granted Class II clearance by TFDA
Taiwan Food and Drug Administration approves Remdesivir to treat patients with severe COVID-19 disease
Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI® for the Treatment of Advanced Prostate Cancer
Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus
CMIC and DCB Signed MOU for Cooperation Partnership
Taiwan-developed Chinese medicine for COVID-19 nearing approval
TLC and Zydus Enter Agreement to Launch AmphoTLC™ in India
The preliminary result of EMA inspection of Trogarzo production in SBL
Taiwanese COVID vaccine developer to present clinical trial results
Novavax COVID-19 vaccine more than 90% effective in U.S. trial
Celltrion says trial shows antibody COVID-19 treatment to be safe and effective
AstraZeneca hits snag in COVID-19 drug development
Vietnam likely to license Nanocovax for emergency use
GSK pays iTeos $625M upfront to join Merck, Roche and the rest in TIGIT immuno-oncology race
CureVac may pick Korea as Asian base for COVID vaccine production
Amazon selling its own COVID-19 test kits for $39.99
CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy
US to spend $3.2B on treatments for COVID-19, other viruses
Bristol-Myers, Eisai in up to $3.1 bln deal to develop cancer drug candidate
Taiwan/ Medigen touts enterovirus vaccine trials
Jacobio Earns $20M AbbVie Milestone
WHO says delta is becoming the dominant Covid variant globally
Amendments to the Act for the Recruitment and Employment of Foreign Professionals Approved
Could a Nasal Spray of Designer Antibodies Help to Beat COVID-19?
Taiwan experts do not recommend mixing AstraZeneca and Moderna
Covid: Asthma drug 'speeds up recovery at home'
Taiwanese firm UBI-Asia inks COVID-19 vaccine deal with Paraguay
Taiwanese mobile health firm iXensor gets CE mark for its COVID-19 digital point-of-care test
AmCham launches initiative to facilitate Taiwan-U.S. trade agreement
Lumosa and DONGWHA Enter Exclusive Distributorship Agreement for LT1001 in Korea
Applied BioCode expands in diagnostic tests and licensing
Some COVID-19 shots may be linked to rare heart problems in teens, CDC says
Drug maker SyneuRx raises TWD400m for CNS and COVID drugs
Inmagene and TWIB Partner to Develop AC-1101 for Multiple Dermatological Immunological Diseases
Acer makes headway in SEA markets with VeriSee DR (Diabetic Retinopathy) medical software
EpiFaith® Expanding to U.S. Military Hospitals After a Newly Awarded Agreement by the Defense Logistics Agency
TLC and Endo Enter Commercialization Agreement
IC company Sunplus ventures into endoscope cameras
A new drug for diabetic foot ulcer launched in Taiwan, aims at global markets by 2030
TLC Announces Details of Stock Swap Transactions
Bora Group's subsidiary Yuta Health becomes Bora Health
ACT Genomics Completes Acquisition of MC Diagnostics
Vaccine developer Adimmune sets up manufacturing site in Indonesia
Orient Pharma enters licensing agreement with Jingxin Pharmaceutical for cholesterol medication
TCI Bio inks manufacturing deal with US company
GlycoNex announces Phase I trial of osteoporosis biosimilar in Japan
Center Ventures disposes of Jacobio shares with returns of $820 million
Olive and ASUS Partner, Bringing AI-Assisted Coding to 775+ Hospitals
Lotus Pharmaceutical overseas drug sales spike in Q1 & Q2
Meridigen announces compassionate use of new stem cell drug
Device taps brain waves to help paralyzed man communicate
DKSH partners with life science innovator Nicoya in Asia
Taiwan’s photonics industry hits TWD$800bn, biomedical photonics thrives
EirGenix Achieves the Fourth Milestone of Its Trastuzumab Biosimilar Licensing Agreement
Qualcomm announces new accelerator program in renewed push against Apple Watch
Taiwan sees rapid growth of clinical trials in cell therapies
Taiwan brings hope for breast cancer patients with new epigenetic drug
Formosa Plastics commits $390m to medical supplies
Taiwan’s biotechnology and pharmaceutical sectors join hands in the post-COVID economy
Tanvex submits BLA for TX05 (Herceptin Biosimilar) to FDA
QPS Supports COVID-19 Vaccine Development In Taiwan
Lotus confirms ANDA filing and patent challenge for generic RYDAPT®
Precision Medicine and Genomics Center opens, targeting cancer and inherited disease
Lumosa Therapeutics Announces Positive Result from LT3001 Phase 2A Clinical Trial in Acute Ischemic Stroke
NaviFUS Receives Approval of Focused Ultrasound Trial to Enhance Radiotherapy
TSTBio’s iProtin system receives CE mark
API manufacture Formosa Laboratories profits TWD181M in H1
KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to Manufacture Generic Product for Filing in Japan
Taiwan’s biopharmaceutical sector embraces onshore manufacturing
Taiwan FDA excels at international regulatory harmonization of medical devices
PharmaEngine expects pancreatic cancer drug sales to top $272M
Genovate Biotechnology unveils three growth strategies
Adimmune boosts productivity of vaccine, adding another 80 million doses
Elderly care startup Jubo Health secures TWD$195M, eyes North America
Senhwa's oral drug Silmitasertib for COVID-19 to conduct phase 2 trail in US
Biomedicine eyed as chief industry of coming decade
United Biomedical seeks appeal after EUA denied
Cerba Research, ACT Genomics to Open Joint Lab Facility in Taiwan Cerba, ACT Genomics
Taiwan FDA hosting 2021 APEC Medical Devices Regulatory Science Center of Excellence (CoE) Workshop
The data of the Phase 3 international multicenter clinical trial and the mechanism of action of Fespixon (ON101) have been published by JAMA Network Open
Adimmune’s Next-Generation COVID-19 Vaccine Receives Clinical Trial Approval from Indonesia
China Medical University Hospital Treats First Patient with Ethos™ Therapy in Taiwan, Expanding Access to Personalized Cancer Care
Taiwan researchers develop breakthrough breast cancer treatment technique
TaiMed Biologics: The results pf phase 3 study of Trogarzo IV Push (study-302)
Taiwanese scientists discover potential cure for diabetes
Taiwan develops world's first ultrasonic vortex thrombolytic device
CYTENA BPS launches microbioreactor with real-time monitoring
Taiwan plans to introduce antiviral drug for treating COVID
TaiMed aiming to apply for US FDA authorization
PharmaEssentia receives regulatory approval in South Korea for BESREMi to treat polycythemia vera
US FDA greenlights TTY Biopharm’s leukemia drug
Medigen’s MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines
Intech testing new asthma inhaler with eye on US market
ITRI and Catcher Technology Jointly Develop the Next-Generation Integrated Electrosurgery System
Acepodia Strengthens Board of Directors and Scientific Advisory Board with Key Appointments
NHRI researchers make lupus breakthrough
U.S. FDA Approves BESREMi® (ropeginterferon alfa-2b-njft) as the Only Interferon for Adults With Polycythemia Vera
COVID-19 nasal spray effective in animal studies
Taiwan explores mix-and-match booster trial of COVID-19 vaccines
Kaohsiung Veterans General Hospital: New treatment for chronic migraines shows promise
Wanfang Hospital develops stenosis detection device
IBMI President Wong: Existing vaccines ‘might protect against Omicron’
A New Electroencephalography-Aided Diagnosis System for Rapid and Accurate Screening of Alzheimer’s Disease and Its Prodromal – Mild Cognitive Impairment.
Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan
Taiwan’s Acura NanoMedicine reduces drug resistance in cancer cells
Senhwa’s Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Medulloblastoma
ASUS Aims to Lead the New Digital Era with Launch of ASUS-NTU Joint Research Center
Adimmune upbeat about flu vaccine sales in 2022
MediBalloon Expands Operations and Establishes Mass Production Capabilities in Taiwan's Medeologix
Tax breaks for biomedical R&D pass legislature
Covid-19 Drug Duo Achievements: GoldenBiotech’s New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review and Licenses for 4 Countries
SyneuRx Announces Oral COVID-19 Antiviral Drug Candidate Pentarlandir® Is Showing Effectiveness Against Both the Omicron and Delta COVID-19 Variants
Taiwan university unveils heart arrhythmia detection app
Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000
NCKU touts diagnostic system in use worldwide
Eisai to launch digital tool CogMate™ in Taiwan and Hong Kong
Advantech Implement First Smart Hospital in Vietnam
Deloitte expects IPOs to double
Taiwanese workplace digital health platform H2U scores $8M in funding
Senhwa's Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Biliary Tract Cancer
Lotus Korean subsidiary received approval of Alymsys®, a biosimilar to Avastin® (bevacizumab)
Taiwanese researchers make world’s first chip virus reader
Working with a Nobel laureate: NYCU and CiRA Foundation at Kyoto University signed a Japan–Taiwan collaborative research agreement that aims to automate various processes in iPS cell manufacturing
Senhwa’s Pidnarulex Receives US FDA Fast Track Designation for the Treatment of Solid Tumors with BRCA1/2, PALB2 and other HR Gene Mutations.
OBI Pharma announces COVID-19 vaccine clinical trials to start in 2022
Taiwan unveils potential mRNA vaccine for all COVID variants including Omicron
Kaohsiung surgeon first female to head ICS
NaviFUS® Model 101 has been chosen for the 2022 Edison Awards Outpatient Treatment Finalist
Medigen vaccine passes Paraguay trial, earns EUA
Taiwan unveils potential mRNA vaccine for all COVID variants including Omicron
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries
Taiwan's NHRI: Survival length of biliary tract cancer patients dramatically prolonged in study of new chemotherapy regimen
The data of SNS812, an anti-Pan-COVID19 siRNA, co-developed by Oneness & MBS and supervised by NTU professors, were published today by EMBO Mol. Medicine
OBI Pharma Enters License Agreement with Odeon Therapeutics for the Rights of OBI-999 and OBI-833 in China, Hong Kong and Macau
Foresee Pharmaceuticals and TRPharm Announce License and Co-Development Agreement
Japan order first from overseas for ITRI test kit
Lotus obtained marketing authorizations for Lenalidomide and Gefitinib in Philippines
NCCN Clinical Practice Guidelines in Oncology Update Recommends BESREMi® for the Treatment of Polycythemia Vera
Biosion, Inc. Licenses BSI04702, An Anti-TROP-2 mAb, to OBI Pharma, Inc. for Worldwide Development and Commercialization Rights as an Antibody Drug Conjugate and Other Derivative Products
Herbal treatment shows promise in reducing virus deaths, institute says
Adimmune revenue soars 25-fold on sales abroad
HCmed, Formosa Laboratories, and Formosa Pharmaceuticals Signed MoU to Form a Global CDMO for Inhalation Treatment Drugs
SOPHiA GENETICS HRD Solution Adopted in Asia Pacific
TaiMed Expands Its Business Model from Biologic Drug Innovator to Contract Development and Manufacturing Organization (CDMO)
TaiGen returns to black due to bonus payment
Taiwan:Health ministry to increase co-payments in national health insurance scheme
EEG breakthrough - towards precision treatment in migraine
Lotus acquires Cialis® (Tadalafil) in Taiwan from Lilly
Asus, Nvidia to jointly build Taiwan’s first supercomputer for medical research
OBI PHARMA ANNOUNCES POSTER PRESENTATIONS AT AACR 2022 ANNUAL MEETING FOR OBI-3424 AND GLOBO H SCIENCE
Ontario Together Fund invests $1.9M in Bora Pharmaceutical Services
CEPI to co-fund Vaxxinity’s pivotal Phase 3 UB-612 heterologous booster trial to combat SARS-CoV-2 variants
Fifty-five drug shortages reported in first two months
Biochemist Chi-Huey Wong receives US ‘Pioneer’ award
SyneuRx completes enrolment in Phase II trial of Covid-19 oral antiviral
Lotus received approval for Alymsys®, a biosimilar to Avastin® (bevacizumab), in Taiwan
Orient EuroPharma gains rights to Contrave for Taiwan
Quarantine-free entry into Taiwan possible in July: Health minister
Taiwan-developed herbal COVID drug works for kids too
ITRI wins two Edison Awards
iXensor Receives Strategic Investment from Rohto Pharmaceutical with A Separate Technology Licensing Agreement
TaiMed Receives from Theratechnologies Notification of Returning Commercialization Rights for Trogarzo in European Territory
Research: Multicolor live-cell imaging identifies asynthetic fission
Belite Bio Announces Pricing of $36 Million Initial Public Offering
Vaxxinity Receives FDA Fast Track Designation for UB-311 for Treatment of Alzheimer’s Disease
Taiwan's NTHU holds opening ceremony for Post-baccalaureate Programme in Medicine
Taiwanese enterovirus vaccine trials successful
Adimmune Supplies over 50% of Government QIV Procurement and Its International Sales Reaches New High
Bora Pharmaceuticals acquires Eden Biologics CDMO Assets Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Kim Forest eyes approval for non-invasive virus test
Formosa Pharmaceuticals and AimMax Therapeutics Announce Successful Top-Line Results from CPN-301 for the Treatment of Inflammation and Pain after Cataract Surgery
BRIM Biotechnology, Inc. and Ora, Inc. announce new partnership to accelerate the development of regenerative peptide therapy, BRM421 for Dry Eye Syndrome
Evofem Biosciences to Decrease Cost of Goods 45 Percent Through New Partnership with Bora Pharmaceutical Services for the Commercial Manufacturing of Phexxi®
Taiwan's Medigen COVID vaccine enters WHO data analysis trial stage
Qisda forms gene tech partnership
Taiwan FDA authorizes PCR test kit production by Terry Gou-backed company
Tungs' Taichung MetroHarbor Hospital in Taiwan latest to achieve Stage 6 EMRAM
IntelliCentrics announces strategic alliance to ensure quality healthcare in Taiwan
Taiwan develops high potent immunotherapy for COVID-19 Omicron variant
Chunghwa Telecom and Thonburi Hospital Collaborate to Create the New Chapter of Thailand’s “Smart Hospital” Services
Foresee Pharmaceuticals Announces European Commission Approval of CAMCEVI® for the Treatment of Advanced Prostate Cancer; Accord Healthcare to Head the E.U. Commercialization
Taiwan develops rapid test for liver function that only requires a drop of blood
Taiwan shortens COVID quarantine to 3 days for all arrivals
Good News from Taiwan Participants in BIO 2022 - Pharmasaga and PrecisemAb Make It to the Start-Up Stadium Finalists Defeating Hundred Teams
Endo Executes Agreement With Taiwan Lipsome Company to Commercialize Phase 3 Orthopedic Product for the Treatment of Osteoarthritis Knee Pain
Tanvex BioPharma and TaiMed Biologics form a business alliance to offer efficient CDMO services in Biologics
Taiwan introduces digitised dialysis management system
Scientists behind mRNA vaccines win Tang Prize
Belite Bio Receives Approval to Initiate LBS-008 Phase 3 Study at CERA Clinical Trial Site in Australia
3 TTA Startups: FaceHeart, iStaging and ible Technology to Win Global Challenge (Coup de Coeur) at VivaTech 2022
UnicoCell and Tzu-Chi Hospital Ophthalmology Research Center collaborate to Open New Horizons of "Vision"
Rakuten Medical Taiwan Announces Commencing a Phase 2 Clinical Trial for Head and Neck Squamous Cell Carcinoma Photoimmunotherapy based on the Alluminox™ platform at 5 Leading Medical Centers
MBI joins TCI Alliance, Benefits of Internationalization Emerge
IPO market advances significantly
Taiwan startups win top prizes at SelectUSA Tech
A powerful investment alliance of Aztiq and Innobic acquires Alvogen’s shares in Lotus and Adalvo in a US$475m deal
Top research institute selects 19 new members
TFBS Biosciences expands state-of-the-art facility for viral vector production in Taiwan
Taiwan, China joint venture to develop inhalation-type drugs
ADC Therapeutics out-licenses Zynlonta in Taiwan and Singapore
Flat Medical Enters the Vascular Access Medtech Domain with its Newly Acquired MDR Certification and New Medical Advisor
Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan
Taiwan reports 1st child with cancer cured by CAR T-cell therapy
Hsueh Jui-yuan named Taiwan's new health minister, Victor Wang heads CECC
Health2Sync and AstraZeneca Taiwan to Kick off Digital Patient Management Programs for Chronic Kidney Diseases
Belite Bio Announces Start of LBS-008 Phase 3 Stargardt Disease Trial
Chi-Huey Wong awarded Tetrahedron Prize for Creativity in Organic Synthesis
NTUH develops treatment for rare deadly condition
ASUS and Tan Tock Seng Hospital co-develop an AI-based tool to improve the accuracy and efficiency of diagnosis in blood diseases
JCR Pharmaceuticals invests in Mycenax Biotech, becomes largest shareholder
SyneuRx Announces Final Results of Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir®
The National University of Asunción's Team Shared Phase III Study Data of MVC COVID-19 Vaccine
Taiwan develops world's first commercial personalised cancer cell profile
Asustek AI platform to help 5G app developers
Taiwan Approves the First Autonomous Neurosurgical Navigation Robot NaoTrac
Formosa Pharmaceuticals And AimMax Therapeutics Announce Successful Top-Line Results From CPN-302 For The Treatment Of Inflammation And Pain After Cataract Surgery
Taiwan and US researchers develop cancer treatment
TTY, Everest form exclusive partnership to introduce to Taiwan a new drug for treating multiple-drug-resistant infection
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022
Point Robotics Receives FDA 510(k) Clearance for its POINT™ Kinguide Robotic-Assisted Surgical System to Push the Boundaries of Precision Spinal Surgeries
Taiwanese AI Startup AESOP Raises $3M to Tackle Medical and Billing Errors
Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals
Ministry eyes US biotech cooperation
Polaris Group Announces Positive Top-Line Results from Phase 2/3 ATOMIC study in Patients with Malignant Pleural Mesothelioma to Assess ADI-PEG 20 with Pemetrexed and Cisplatin
GSK transforms to improve pharmaceutical operations
Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies and Establishes One-Stop Shop Mass Production Facilities in Taiwan
Healthcare+ Expo 2022 stages digital transformation solutions and expands supply-demand footprint across markets
New era of smart healthcare centre established in Pulau Pinang
Taiwan-based Lotus Pharma launches drug for multiple myeloma in Brazilian market
Chang Gung Memorial Hospital ranks second globally in 2022 HIMSS Digital Health Indicator
China Medical University Hospital ranks global third in 2022 HIMSS Digital Health Indicator
Hospital touts new world-class center for surgical training
Taiwan-based Compal Electronics launches innovative therapeutic medical devices
PharmaEssentia snagged $462M, the largest overseas fundraising to Taiwan
First Asian medical team departs Taiwan for Ukraine
TVGH unveils first cancer center of its kind in Taiwan
Taiwan's NHIA and UK's NICE Sign Partnership Agreement to Advance Health Technology Assessment, Optimize Resource Allocation
NCKU Hospital inks MOU with India's Yashoda Super Speciality Hospitals
Taiwan's Academia Sinica signs mRNA agreement with Moderna
Singapore's Inex Innovate buys Taiwan genomics business of Yourgene for $4 M
Pharmosa announced the collaboration with Liquidia Technologies, Inc. For L606 in North America

■ Most Watched

Top 20 biomedical compani...

Taiwan business watch 202...

A Few Years After Launch,...

Net Income of Biomedical ...

■ Industry Watch

Top 20 biomedical compani...

Taiwan business watch 202...

Taiwan biomedical sector ...

MORE...

■ IBMI News

Tech Giants Quanta, ASUS,...

SNQ 2023 Award Ceremony: ...

National Innovation Award...

MORE...